Literature DB >> 8738513

Allergen avoidance in infancy and allergy at 4 years of age.

D W Hide1, S Matthews, S Tariq, S H Arshad.   

Abstract

In an attempt to prevent or reduce the manifestations of atopic disease, a group of infants considered to be genetically at high risk of atopy was entered in a prenatally randomized, controlled study. A prophylactic group (n = 58) was either breast-fed with their mothers excluding foods regarded as highly antigenic from their diets, or given an extensively hydrolysed formula. In addition, strenuous efforts were made to reduce exposure to the house-dust mite by application of acaricide to the bedroom and living room carpets and upholstered furniture. A control group (n = 62) was fed conventionally by breast or on formula, and no specific environmental measures were taken. The results (previously reported) after 1 year showed significantly less total allergy, asthma, and eczema in the prophylactic group. Similar results were obtained at 2 years although the reduction in asthma no longer achieved statistical significance. However, there was significantly less sensitization, as shown by a battery of skin prick tests (SPTs), to both dietary allergens and aeroallergens in the prophylactic group. All the children have now been reviewed at the age of 4 years, and SPTs to a wide range of dietary allergens and aeroallergens have been performed. The control group continues to show more total allergy (odds ratio [OR] 2.73, 95% confidence interval [CI] 1.21-6.13, P < 0.02), definite allergy (allergic symptoms plus positive SPT) (OR 5.6, CI 1.8-17.9, P < 0.005), and eczema (OR 3.4, CI 1.2-10.1, P < 0.05). More control children have positive SPTs (OR 3.7, CI 1.3-10.0, P < 0.02). A dual approach to the prevention of allergic disease, avoiding as far as possible sensitization to food and aeroallergens, significantly reduces the risk of atopic disease. This should be reserved for infants considered at very high risk of atopy, and close medical and dietetic supervision must be available.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738513

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  36 in total

Review 1.  Worldwide variations in the prevalence of atopic symptoms: what does it all mean?

Authors:  J O Warner
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Is allergen exposure the major primary cause of asthma?

Authors:  N Pearce; J Douwes; R Beasley
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

3.  Asthma in preschool children: prevalence and risk factors.

Authors:  M M Haby; J K Peat; G B Marks; A J Woolcock; S R Leeder
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

4.  Maternal compliance with nutritional recommendations in an allergy preventive programme.

Authors:  A Schoetzau; U Gehring; K Franke; A Grübl; S Koletzko; A von Berg; D Berdel; D Reinhardt; C P Bauer; H-E Wichmann
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

Review 5.  Clinical effects of allergen avoidance.

Authors:  A Custovic; A Woodcock
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

6.  The role of airborne proteins in atopic dermatitis.

Authors:  Sarah Grim Hostetler; Benjamin Kaffenberger; Todd Hostetler; Matthew J Zirwas
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

Review 7.  Dust mite allergen avoidance as a preventive and therapeutic strategy.

Authors:  Aida Semic Jusufagic; Angela Simpson; Ashley Woodcock
Journal:  Curr Allergy Asthma Rep       Date:  2006-11       Impact factor: 4.806

8.  Infant sleeping environment and asthma at 7 years: a prospective cohort study.

Authors:  Leigh F Trevillian; Anne-Louise Ponsonby; Terence Dwyer; Andrew Kemp; Jennifer Cochrane; Lynette L-Y Lim; Allan Carmichael
Journal:  Am J Public Health       Date:  2005-12       Impact factor: 9.308

Review 9.  Preventing food allergy.

Authors:  Abbas Khakoo; Gideon Lack
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.806

Review 10.  The allergy and immunology specialist: what is the role in the treatment of skin disease?

Authors:  Ernest N Charlesworth
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.